Unknown

Dataset Information

0

Investigation of serum proteome homeostasis during radiation therapy by a quantitative proteomics approach.


ABSTRACT: The purpose of the present study is to analyze the serum proteome of patients receiving Radiation Therapy (RT) at different stages of their treatment to discovery candidate biomarkers of the radiation-induced skin lesions and the molecular pathways underlying the radiation signatures. Six stages of RT treatment were monitored from patients treated because of brain cancer: before starting the treatment, during the treatment (four time points), and at 4 weeks from the last RT dose. Serum samples were analyzed by a proteomics approach based on the Data Independent Acquisition (DIA) mass spectrometry (MS). RT induced clear changes in the expression levels of 36 serum proteins. Among these, 25 proteins were down- or up-regulated significantly before the emergence of skin lesions. Some of these were still deregulated after the completion of the treatment. Few days before the appearance of the skin lesions, the levels of some proteins involved in the wound healing processes were down-regulated. The pathway analysis indicated that after partial body irradiation, the expression levels of proteins functionally involved in the acute inflammatory and immune response, lipoprotein process and blood coagulation, were deregulated.

SUBMITTER: Ouerhani A 

PROVIDER: S-EPMC6663990 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Investigation of serum proteome homeostasis during radiation therapy by a quantitative proteomics approach.

Ouerhani Amira A   Chiappetta Giovanni G   Souiai Oussema O   Mahjoubi Halima H   Vinh Joelle J  

Bioscience reports 20190729 7


The purpose of the present study is to analyze the serum proteome of patients receiving Radiation Therapy (RT) at different stages of their treatment to discovery candidate biomarkers of the radiation-induced skin lesions and the molecular pathways underlying the radiation signatures. Six stages of RT treatment were monitored from patients treated because of brain cancer: before starting the treatment, during the treatment (four time points), and at 4 weeks from the last RT dose. Serum samples w  ...[more]

Similar Datasets

| S-EPMC2556021 | biostudies-literature
| S-EPMC5316641 | biostudies-other
| S-EPMC3226402 | biostudies-literature